carlisle & Associates
generic drug updates News contact carlisle medical
news
generic drug updates
January Generic Drug Releases
Released: 01/09/2012
By: Theron Mindek

Generic Ritalin LA® Capsules Launched

Actavis Group commenced shipping their AB rated generic equivalent of Novartis' Ritalin LA® Capsules in the 20, 30, and 40mg strengths (100-count bottle).
Ritalin LA® (methylphenidate hydrochloride) extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
This drug is classified as a CII medication. New prescriptions (hard copies) will be required at the pharmacy in order to dispense the new generic version.


Generic Clobex® Lotion and Shampoo Launched

Actavis Group commenced shipping their AB rated generic equivalent of Clobex® (Clobetasol) lotion and shampoo 0.05% in the 2 and 4 ounce sizes for the lotion, and 4 ounce size for the shampoo.
Clobex® (clobetasol propionate) Shampoo, 0.05% is a super-high potent topical corticosteroid formulation indicated for the treatment of moderate to severe forms of scalp psoriasis in subjects 18 years of age and older.


Authorized Generic of Ryzolt® Tablets Launched

Rhodes Pharmaceuticals launched tramadol hydrochloride extended-release tablets, the authorized generic (AG) of Purdue Pharma’s branded product, Ryzolt®.
Ryzolt® (tramadol hydrochloride) is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

All generics are in stock and available to all claimants covered by Carlisle Medical Home Delivery Pharmacy.


<<Back
 
Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer